Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

DenmarkBack to Denmark

Clinical trials in Silkeborg – page 13

687 clinical trials in Silkeborg, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Silkeborg at a glance
687
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

687 trials in Silkeborg

Open in trial search

Adult T-cell lymphoma/leukaemia refractory

Recruiting

Study Comparing Duvelisib with Gemcitabine or Bendamustine for Patients with Relapsed or Resistant T Cell Lymphoma Originating from T Follicular Helper Cells

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Duvelisib
  • Sponsor:Secura Bio Limited

Chronic lymphocytic leukaemia+1

Recruiting

Study on Venetoclax, Obinutuzumab, and Pirtobrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Obinutuzumab
  • Sponsor:University Of Cologne

Urinary incontinence+7

Recruiting

Study on the Effects of Vaginal Estrogen Treatment with Nomegestrol Acetate and Estradiol Hemihydrate on Blood Clotting in Postmenopausal Women with Vaginal Atrophy

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Nomegestrol Acetate
  • Sponsor:Aarhus University Hospital

Hypoparathyroidism

Recruiting

Study on Indapamide for Patients with Chronic Post-Surgical Hypoparathyroidism

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Indapamide hemihydrate
  • Sponsor:Region Midtjylland

Prader-Willi syndrome

Recruiting

Study on the Effects of Pitolisant Hydrochloride for Patients with Prader-Willi Syndrome

Investigational
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Pitolisant hydrochloride
  • Sponsor:Harmony Biosciences LLC

Hyperparathyroidism primary

Recruiting

Study on Zoledronic Acid and Placebo Before Parathyroid Surgery in Patients with Primary Hyperparathyroidism

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Region Midtjylland

Malignant glioma

Recruiting

Study Comparing Lomustine Alone and Lomustine with Bevacizumab for Patients with Recurrent Glioblastoma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Region Hovedstaden

Ischaemic stroke

Recruiting

Study on the Effectiveness of Tenecteplase in Patients with Acute Ischemic Stroke Taking Rivaroxaban, Apixaban, or Edoxaban

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Alteplase
  • Sponsor:Oslo Universitetssykehus HF

Acute myeloid leukaemia

Recruiting

Study on Revumenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Diffuse large B-cell lymphoma

Recruiting

Study of Zilovertamab Vedotin and Drug Combination for Untreated Diffuse Large B-Cell Lymphoma Patients

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Merck Sharp & Dohme LLC

Follicular lymphoma

Recruiting

Study on Rituximab, Lenalidomide, and Tafasitamab for Treating High-Risk and Low-Risk Follicular Lymphoma Patients

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Lenalidomide
  • Sponsor:Karolinska University Hospital

Intensive care

Recruiting

Evaluation of enoxaparin, dalteparin, nadroparin, tinzaparin and human albumin in adults admitted to intensive care unit with acute critical illness

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Dalteparin Sodium
  • Sponsor:Region Hovedstaden

Other cities in Denmark

The busiest research cities in the country

All 45 cities in Denmark

Clinical research in Silkeborg

What the registry says about research in the country

01 Pain Management & Anesthesia

Innovative research focusing on post-surgical pain management and anesthetic techniques, particularly studying the effectiveness of Popliteal Plexus Block in knee surgeries.

  • Post-surgical pain control
  • Local anesthetic optimization
  • Multimodal pain management

Studies evaluating different volumes of anesthetic agents to improve patient outcomes after orthopedic procedures.

02 Musculoskeletal Disorders

Comprehensive trials investigating treatments for various joint and muscle conditions, including hand osteoarthritis and Dupuytren Contracture.

  • Arthritis management
  • Joint mobility improvement
  • Novel therapeutic approaches

Research exploring both medication-based and surgical interventions for musculoskeletal conditions.

03 Chronic Disease Management

Advanced research into chronic conditions including COPD and Type 2 diabetes, with focus on screening and treatment optimization.

  • Respiratory health
  • Cardiovascular screening
  • Disease prevention strategies

Innovative approaches to managing long-term conditions through personalized treatment strategies.

Back to DenmarkAll countries
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.